Name
Oxford-Style Debate: Is Aging a Disease or a Process?
Eric Verdin, M.D. Andrea Gartenbach, M.D. Daniel Krizek Karl Pfleger
Speakers
Eric Verdin, M.D., The Buck Institute for Research on Aging
Andrea Gartenbach, M.D., Art of Longevity
Daniel Krizek, Citadel
Karl Pfleger, AgingBiotech.info
Moderator/s

Jordan Shlain, M.D., Private Medical

Conversants

Jean Drouin M.D., Clarify Health
Stefano Natella, Guggenheim Partners

Date
Thursday, October 24, 2024
Time
8:00 PM - 9:15 PM
Location
The Social
Description

Aging shares many characteristics with diseases, such as the progressive decline in physiological function and the increased risk of various pathologies. But research has shown that genetic mutations and epigenetic changes can accelerate or slow down aging processes, implying that aging can be influenced and potentially treated like a disease. Opponents argue that the rise of longevity movements in society have led to opportunists and charlatans eager to profit off false hope. Proponents believe science and engineering can outwit nature. Whose case will win the day?